Union européenne - français - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Union européenne - français - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Union européenne - français - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).

Union européenne - français - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

alfasigma schweiz ag - hydroxocobalaminum, l-o-phosphothreoninum, glutaminum, l-o-phosphoserinum, arginini hydrochloridum - quand bébé grandit - hydroxocobalaminum 0.5 mg, l-o-phosphothreoninum 10 mg, glutaminum 60 mg, l-o-phosphoserinum 40 mg, arginini hydrochloridum 100 mg, sorbitolum liquidum non cristallisabile 9 g, e 211 30 mg, natrii hydroxidum, aromatica, aqua ad solutionem pro vitro 10 ml corresp. natrium 8.1 mg. - roborans - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. grossmann ag, pharmaca - retinoli palmitas, cholecalciferolum, int-rac-alpha-tocopherylis acetas, thiamini nitras, riboflavinum, pyridoxini hydrochloridum, cyanocobalaminum, nicotinamidum, calcium pantothenas, l'acide ascorbicum, le calcium, le magnésium, le cuivre, le fer, manganum, le molybdène, le zinc - comprimés effervescents - vitamina: retinoli palmitas 3333 u. i., cholecalciferolum 200 u. i., int-rac-alpha-tocopherylis acetas 5 mg, thiamini nitras 10 mg, riboflavinum 4 mg, pyridoxini hydrochloridum 5 mg, cyanocobalaminum 5 µg, nicotinamidum 50 mg, calcium pantothenas 20 mg, acide ascorbicum 75 mg, minéraux: calcium 11.2 mg, magnésium 6,25 mg, cuivre 0,1 mg, fer à 0,1 mg, manganum 0,1 mg, molybdène 90 µg, zinc 0,3 mg, arom.: saccharinum natricum et d'autres, excipiens pro compresso. - vitamines et minéraux-préparation - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

dr. grossmann ag, pharmaca - thiamini nitras, riboflavini natrii phosphas, pyridoxini hydrochloridum, nicotinamidum, biotinum, cyanocobalaminum, calcium pantothenas, l'acide ascorbicum, de calcium - comprimés effervescents - thiamini nitras 15 mg, riboflavini natrii phosphas 15 mg, pyridoxini hydrochloridum 10 mg, nicotinamidum 50 mg, biotinum 0,15 mg, cyanocobalaminum 10 µg, de calcium pantothenas 25 mg, acide ascorbicum 1 g de calcium 117 mg de calcium que carbonas et de calcium glycerophosphas, arom.: natrii cyclamas et d'autres, excipiens pro compresso. - complexe de vitamine b-préparation avec de la vitamine c et de calcium - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - celiprololi hydrochloridum - comprimés pelliculés - celiprololi hydrochloridum 200 mg, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, e 171, hypromellosum, macrogolum 400, macrogolum 6000, pro compresso obducto corresp. natrium 65 µg. - betablocker - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

schülke & mayr ag - octenidini dihydrochloridum, l'alcool propylicus, l'alcool isopropylicus - solution - octenidini dihydrochloridum la dose de 1 mg d'alcool propylicus 300 mg, de l'alcool isopropylicus 450 mg, excipiens à la solution pro 1.g. - la désinfection de la peau, l'hygiène des mains - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - loperamidi hydrochloridum - loperamid streuli 2 mg - loperamidi hydrochloridum 2 mg, lactosum monohydricum 225.5 mg, talc, kapselhülle: gélatine, pro de la capsule. - antidiarrhoikum - synthetika